Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89934268

HLA-DR Rat anti-Human, Clone: YE2/36 HLK, Abnova™

Catalog No. 89934268 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
125 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-934-268 125 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-934-268 Supplier Abnova Corporation Supplier No. MAB12686
Add to Cart
Add to Cart

Description

Rat monoclonal antibody raised against human HLA-DR.

Specifications

Antigen HLA-DR
Applications Flow Cytometry, Immunohistochemistry (Frozen), Immunohistochemistry (PFA fixed)
Classification Monoclonal
Clone YE2/36 HLK
Conjugate Unconjugated
Description Rat monoclonal antibody raised against human HLA-DR.
Dilution Flow Cytometry (1:50-1:100) Immunohistochemistry (Frozen sections) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (10 ug/mL) The optimal working dilution should be determined by the end user.
Formulation In PBS (0.09% sodium azide).
Host Species Rat
Immunogen eHR-B Ramos cells
Purification Method Affinity purification
Quantity 125 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
Form Liquid
Isotype IgG2a
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.